|
51
|
245
|
5j4sA |
Alpha-chymotrypsin from bovine pancreas in complex with a modified bowman-birk inhibitor from soybean |
|
60
|
254
|
5i46H |
Factor viia in complex with the inhibitor (2r,15r)-2-[(1-aminoisoquinolin-6-yl)amino]-8-fluoro-7-hydroxy-4,15,17-trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione |
|
144
|
605
|
5i25A |
Human recombinant coagulation fxi in complex with a peptide derived from human high molecular weight kininogen (hkp) |
|
52
|
259
|
5hu6C |
Structure of the t. brucei haptoglobin-haemoglobin receptor bound to human haptolgobin-haemoglobin |
|
56
|
223
|
5gxpA |
Cationic trypsin with gol/pge as dimer at ph 4.6 |
|
61
|
229
|
5fckA |
Complement factor d in complex with compound 5 |
|
52
|
198
|
9lprA |
Structural basis for broad specificity in alpha-lytic protease mutants |
|
55
|
240
|
7estE |
Interaction of the peptide cf3-leu-ala-nh-c6h4-cf3(tfla) with porcine pancreatic elastase. x-ray studies at 1.8 angstroms |
|
59
|
240
|
9estA |
Structural study of porcine pancreatic elastase complexed with 7-amino-3-(2-bromoethoxy)-4-chloroisocoumarin as a nonreactivatable doubly covalent enzyme-inhibitor complex |
|
63
|
240
|
8estE |
Reaction of porcine pancreatic elastase with 7-substituted 3-alkoxy-4-chloroisocoumarins: design of potent inhibitors using the crystal structure of the complex formed with 4-chloro-3-ethoxy-7-guanidino-isocoumarin |
|
53
|
198
|
8lprA |
Structural basis for broad specificity in alpha-lytic protease mutants |
|
55
|
257
|
8kme2 |
Crystal structure of human alpha-thrombin inhibited with sel2770. |
|
53
|
198
|
7lprA |
Structural basis for broad specificity in alpha-lytic protease mutants |
|
52
|
259
|
7kmeH |
Crystal structure of human alpha-thrombin inhibited with sel2711. |
|
53
|
198
|
6lprA |
Structural basis for broad specificity in alpha-lytic protease mutants |
|
52
|
224
|
6gfiA |
Structure of human mesotrypsin in complex with appi variant t11v/m17r/i18f/f34v |
|
59
|
227
|
6fuiA |
Complement factor d in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1h-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol |
|
54
|
230
|
6fugA |
Complement factor d in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1h-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol |
|
55
|
228
|
6ftyA |
Complement factor d complexed with compound 5 |
|
57
|
228
|
6fuhA |
Complement factor d in complex with the inhibitor (4-((3-(aminomethyl)phenyl)amino)quinazolin-2-yl)-l-valine |
|
61
|
232
|
6futA |
Complement factor d in complex with the inhibitor (s)-3'-(aminomethyl)-n-(1,2,3,4-tetrahydronaphthalen-1-yl)-[1,1'-biphenyl]-3-carboxamide |
|
57
|
228
|
6fujA |
Complement factor d in complex with the inhibitor n-(3'-(aminomethyl)-[1,1'-biphenyl]-3-yl)-3-methylbutanamide |
|
58
|
228
|
6ftzA |
Complement factor d complexed with compound 6 |
|
59
|
223
|
6fidA |
Bovine trypsin solved by s-sad on id30b |
|
47
|
218
|
6f5mA |
Crystal structure of highly glycosylated human leukocyte elastase in complex with a thiazolidinedione inhibitor |
|
69
|
314
|
6ew9A |
Crystal structure of degs stress sensor protease in complex with activating dnrlglvyqf peptide |
|
57
|
240
|
6estA |
Interaction of the peptide cf3-leu-ala-nh-c6h4-cf3(tfla) with porcine pancreatic elastase. x-ray studies at 1.8 angstroms |
|
58
|
257
|
6eo9H |
Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor |
|
58
|
256
|
6eo8H |
Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor |
|
54
|
223
|
6dzfA |
Orthorhombic trypsin cryocooled to 100 k with 20% xylose as cryoprotectant |
|
67
|
257
|
6cymA |
Reversible covalent direct thrombin inhibitors |
|
52
|
238
|
6c0sA |
Factor xia in complex with the inhibitor methyl (4-{6-[(1s)-2-[(3r)-1-acetylpiperidin-3-yl]-1-({(2e)-3-[5-chloro-2- (1h-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)ethyl]-3-chloropyridazin-4-yl}phenyl) carbamate |
|
67
|
582
|
6c2wA |
Crystal structure of human prothrombin mutant s101c/a470c |
|
80
|
582
|
6bjrA |
Crystal structure of prothrombin mutant s101c/a470c |
|
56
|
223
|
6b6oA |
Orthorhombic trypsin cryocooled to 100 k with 20% xylose as cryoprotectant |
|
57
|
223
|
6b6rA |
Orthorhombic trypsin cryocooled to 100 k with 50% mpd as cryoprotectant |
|
50
|
243
|
6b74B |
Structures of the two-chain human plasma factor xiia co-crystallized with potent inhibitors |
|
45
|
243
|
6b77B |
Structures of the two-chain human plasma factor xiia co-crystallized with potent inhibitors |
|
58
|
223
|
6b6qA |
Orthorhombic trypsin cryocooled to 100 k with 50% xylose as cryoprotectant |
|
57
|
223
|
6b6nA |
Orthorhombic trypsin (295 k) in the presence of 50% mpd |
|
59
|
223
|
6b6pA |
Orthorhombic trypsin cryocooled to 100 k with 30% xylose as cryoprotectant |
|
56
|
223
|
6b6tA |
Orthorhombic trypsin cryocooled to 100 k with 50% methanol as cryoprotectant |
|
53
|
223
|
6b6sA |
Orthorhombic trypsin cryocooled to 100 k with 50% ethanol as cryoprotectant |
|
56
|
236
|
6aodC |
Fxia antibody complex |
|
57
|
223
|
6avlA |
Orthorhombic trypsin (295 k) in the presence of 50% xylose |
|
56
|
224
|
5zfhA |
Mouse kallikrein 7 |
|
53
|
224
|
5yjkA |
Human kallikrein 7 in complex with 1,4-diazepane-7-one 1-acetamide derivative |
|
54
|
246
|
5yc6U |
The crystal structure of upa in complex with 4-bromobenzylamirne at ph4.6 |
|
46
|
226
|
5yjpA |
Human chymase in complex with 3-(ethoxyimino)-7-oxo-1,4-diazepane derivative |
|
54
|
224
|
5y9lA |
Human kallikrein 7 in complex with 1,3,6-trisubstituted 1,4-diazepane-7-one |
